Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01OSN
|
|||
| Former ID |
DNCL001906
|
|||
| Drug Name |
Riferminogene pecaplasmid
|
|||
| Synonyms |
Temusi (TN)
Click to Show/Hide
|
|||
| Indication | Critical limb ischemia [ICD-11: BD4Y; ICD-9: 459.89] | Discontinued in Phase 3 | [1] | |
| Company |
Sanofi-aventis
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011879) | |||
| REF 2 | Riferminogene pecaplasmide. Am J Cardiovasc Drugs. 2010;10(5):343-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.